Cardinal Health reports $67.5 billion in first-quarter revenue
Cardinal Health reported first-quarter fiscal 2027 revenue of $67.5 billion, a 5.5% increase year-over-year. The quarter ended September 30, 2026.
Key points
- During the first quarter, Cardinal Health completed a $500 million share repurchase.
- Profit in the Global Medical Products and Distribution segment fell 28% year-over-year to $33 million, with revenue flat at $3.2 billion.
Financial results and strategic updates
During the first quarter, Cardinal Health completed a $500 million share repurchase. The company signed a binding letter of intent to extend distribution agreements with CVS Health. It also announced $1.0 billion in additional uncommitted revolving credit facilities, a pool of capital for operating needs.
In October 2026, the company reported that the agreement with CVS Health extends until June 2032. This extension reflects the current scope of distribution services.
Revenue by quarter, $B
Sector context: 36 covered companies in Health Care reported a median revenue change of +7.2% YoY in their latest filings.
Risks and uncertainties
Profit in the Global Medical Products and Distribution segment fell 28% year-over-year to $33 million, with revenue flat at $3.2 billion. Terms of the updated agreement with CVS Health and their impact on future revenue were not disclosed.
Key performance metrics
Profitability trends in the Global Medical Products and Distribution segment are key for evaluating company performance. Information on the use of credit facilities is also significant, as it reflects current liquidity.
Original sources
- 8-K EX-99.1 filing, November 5, 2026
- financial data (XBRL)
- 8-K filing, October 1, 2026
- 8-K EX-99.1 filing, October 1, 2026
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Cardinal Health
A notification in your browser or on your phone when we publish about Cardinal Health. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
